---
title: O.C.G.A. § 31-15A-2. Definitions.
collection: code
id: 31-15A-2
cite_as: O.C.G.A. § 31-15A-2 (2025)
canonical_url: https://georgiacommons.org/code/31-15A-2
md_url: https://georgiacommons.org/code/31-15A-2.md
text_url: https://georgiacommons.org/code/31-15A-2/text
source_url: https://www.legis.ga.gov/api/document/docs/default-source/joint-features-document-library/t31-(v23)-2025-pdf.pdf?sfvrsn=da7ded69_0#page=828
date: 2025
status: active
corpus_version: 2025-supplement-89aa39ab3c68
license: CC0-1.0
publisher: Georgia Commons, an independent project of Georgia Civic Data. Not the State of Georgia. Not legal advice.
up: https://georgiacommons.org/code/31-15A.md
previous: https://georgiacommons.org/code/31-15A-1.md
next: https://georgiacommons.org/code/31-15A-3.md
index: https://georgiacommons.org/code/index.md
version: the only printed version
in_force: true
current_through: Including Acts of the 2025 Session of the General Assembly of Georgia
heading_path: HEALTH / BONE MASS MEASUREMENT COVERAGE
---

# O.C.G.A. § 31-15A-2. Definitions.

As used in this chapter, the term:

(1) “Accident and sickness insurance benefit plan, policy, or contract” has the meaning provided by paragraph (1) of subsection (a) of Code Section 33-24-28.1, provided that such term shall not include a limited benefit insurance policy as defined in paragraph (4) of subsection (f) of Code Section 33-30-12.

(2) “Bone mass measurement” means a radiologic or radioisotopic procedure or other technologies approved by the United States Food and Drug Administration and performed on an individual for the purpose of identifying bone mass or detecting bone loss.

(3) “Qualified individual” means an:

(A) Estrogen-deficient woman or individual at clinical risk of osteoporosis as determined directly or indirectly by a physician and who is considering treatment;

(B) Individual with osteoporotic vertebral abnormalities;

(C) Individual receiving long-term glucocorticoid (steroid) therapy;

(D) Individual with primary hyperparathyroidism; or

(E) Individual being monitored directly or indirectly by a physician to assess the response to or efficacy of approved osteoporosis drug therapies.

## History

Code 1981, § 31-15A-2, enacted by Ga. L. 1998, p. 877, § 2.